Published in J Lipid Res on December 07, 2011
ELOVL5 mutations cause spinocerebellar ataxia 38. Am J Hum Genet (2014) 0.90
Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective. Drug Metab Rev (2012) 0.81
Electrophysiological changes in optic neuropathy of streptozotocin induced diabetic rats. J Med Life (2013) 0.81
Pregnane xenobiotic receptors and membrane progestin receptors: role in neurosteroid-mediated motivated behaviours. J Neuroendocrinol (2013) 0.77
Transcriptomics of cortical gray matter thickness decline during normal aging. Neuroimage (2013) 0.77
Effects of experimental diabetes on C/EBP proteins in rat hippocampus, sciatic nerve and ganglia. Cell Mol Neurobiol (2013) 0.76
The pregnane xenobiotic receptor, a prominent liver factor, has actions in the midbrain for neurosteroid synthesis and behavioral/neural plasticity of female rats. Front Syst Neurosci (2014) 0.76
Does Endurance Training Compensate for Neurotrophin Deficiency Following Diabetic Neuropathy? Iran Red Crescent Med J (2016) 0.75
The lipogenic regulator Sterol Regulatory Element Binding Factor-1c is required to maintain peripheral nerve structure and function. Springerplus (2015) 0.75
Attenuation of diet-induced obesity and induction of white fat browning with a chemical inhibitor of histone deacetylases. Int J Obes (Lond) (2016) 0.75
Supplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin-Potential for Preventing or Slowing the Progression of Diabetic Complications. Healthcare (Basel) (2017) 0.75
Photobiostimulation reverses allodynia and peripheral nerve damage in streptozotocin-induced type 1 diabetes. Lasers Med Sci (2017) 0.75
Standards of medical care in diabetes--2007. Diabetes Care (2007) 12.35
SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell (1994) 7.10
Role of LXRs in control of lipogenesis. Genes Dev (2000) 6.98
Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem (1999) 4.48
Myelination in rat brain: method of myelin isolation. J Neurochem (1973) 4.01
Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc Natl Acad Sci U S A (2004) 3.73
Lipid-protein interactions in biological membranes: a structural perspective. Biochim Biophys Acta (2003) 3.44
The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care (2003) 3.12
LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Annu Rev Physiol (2006) 3.11
Diabetic neuropathies. Diabetologia (2000) 2.30
Selective coactivator interactions in gene activation by SREBP-1a and -1c. Mol Cell Biol (2004) 1.75
Molecular dissection of the myelinated axon. Ann Neurol (1993) 1.73
Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia (2005) 1.64
Myelination in rat brain: changes in myelin composition during brain maturation. J Neurochem (1973) 1.59
SREBP-2 regulates gut peptide secretion through intestinal bitter taste receptor signaling in mice. J Clin Invest (2008) 1.58
Ultrastructural dimensions of myelinated peripheral nerve fibres in the cat and their relation to conduction velocity. J Physiol (1980) 1.53
Sampling schemes for estimating nerve fibre size. I. Methods for nerve trunks of mixed fascicularity. J Anat (1984) 1.50
Myelin synthesis in the peripheral nervous system. Prog Neurobiol (2000) 1.47
Quantitative study of the non-circularity of myelinated peripheral nerve fibres in the cat. J Physiol (1980) 1.33
Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models. J Lipid Res (2010) 1.31
Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis. Neuroscience (2006) 1.17
Role of the Schwann cell in diabetic neuropathy. Int Rev Neurobiol (2002) 1.17
Precise and global identification of phospholipid molecular species by an Orbitrap mass spectrometer and automated search engine Lipid Search. J Chromatogr A (2010) 1.16
Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. N Engl J Med (1988) 1.15
Diabetic neuropathy--a continuing enigma. Diabetes Metab Res Rev (2001) 1.14
Sampling schemes for estimating nerve fibre size. II. Methods for unifascicular nerve trunks. J Anat (1984) 1.10
Diabetes epidemiology: guiding clinical and public health practice: the Kelly West Award Lecture, 2006. Diabetes Care (2007) 1.07
SCAP is required for timely and proper myelin membrane synthesis. Proc Natl Acad Sci U S A (2009) 1.05
Reversible diabetic nerve dysfunction: structural correlates to electrophysiological abnormalities. Ann Neurol (1985) 1.01
Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. Course of development and effects of insulin treatment. Brain (1999) 1.00
Interplay between LXR and Wnt/β-catenin signaling in the negative regulation of peripheral myelin genes by oxysterols. J Neurosci (2011) 1.00
Evaluation of neuroactive steroid levels by liquid chromatography-tandem mass spectrometry in central and peripheral nervous system: effect of diabetes. Neurochem Int (2007) 0.98
SREBP-1c expression in Schwann cells is affected by diabetes and nutritional status. Mol Cell Neurosci (2007) 0.94
Neuroactive steroids and peripheral neuropathy. Brain Res Rev (2007) 0.94
Regulation of oleoyl-CoA synthesis in the peripheral nervous system: demonstration of a link with myelin synthesis. J Neurochem (1998) 0.92
Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged rats. Neurobiol Aging (2003) 0.91
Neuroactive steroids prevent peripheral myelin alterations induced by diabetes. Neurosci Lett (2006) 0.91
A study of lipid components in brain of the 'Jimpy' mouse, a mutant with myelin deficiency. J Neurochem (1969) 0.88
An update on electrophysiological studies in neuropathy. Curr Opin Neurol (2003) 0.88
Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats. Horm Behav (2009) 0.87
Activation of the liver X receptor increases neuroactive steroid levels and protects from diabetes-induced peripheral neuropathy. J Neurosci (2010) 0.84
Peripheral nerves: a target for the action of neuroactive steroids. Brain Res Brain Res Rev (2005) 0.83
Alterations in mRNA expression of myelin proteins in the sciatic nerves and brains of streptozotocin-induced diabetic rats. Neurochem Res (2007) 0.83
Diabetic polyneuropathy. Axonal or demyelinating? Electromyogr Clin Neurophysiol (2002) 0.80
The non-synchronous synthesis of myelin components during early stages of myelination in the rat optic nerve. J Neurochem (1976) 0.79
Peripheral diabetic neuropathy and polyunsaturated fatty acid supplementations: natural sources or biotechnological needs? Cell Mol Biol (Noisy-le-grand) (2004) 0.78
Is the 5 alpha-reductase-3 alpha-hydroxysteroid dehydrogenase complex associated with the myelin in the peripheral nervous system of young and old male rats? Endocr Regul (1992) 0.77
Fluidity of the myelin sheath in the peripheral nerves of diabetic rats. Biochim Biophys Acta (2001) 0.77
LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell (2004) 4.20
The nuclear receptor LXR is a glucose sensor. Nature (2006) 2.83
Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc Natl Acad Sci U S A (2003) 2.50
The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARgamma expression. Cell Metab (2007) 2.32
Gene set enrichment in eQTL data identifies novel annotations and pathway regulators. PLoS Genet (2008) 2.32
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. Lancet Neurol (2012) 1.95
Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit Rev Oncol Hematol (2011) 1.82
Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci U S A (2004) 1.65
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients. J Neurol Neurosurg Psychiatry (2013) 1.55
Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial. Hypertension (2011) 1.54
T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR. FEBS Lett (2007) 1.54
The synaptic proteins β-neurexin and neuroligin synergize with extracellular matrix-binding vascular endothelial growth factor a during zebrafish vascular development. Arterioscler Thromb Vasc Biol (2012) 1.50
Telomere-independent Rap1 is an IKK adaptor and regulates NF-kappaB-dependent gene expression. Nat Cell Biol (2010) 1.47
Actions of estrogens on glial cells: Implications for neuroprotection. Biochim Biophys Acta (2009) 1.46
TLE3 is a dual-function transcriptional coregulator of adipogenesis. Cell Metab (2011) 1.46
Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine. Clin Cancer Res (2003) 1.45
Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro Oncol (2012) 1.44
Coordinated control of cholesterol catabolism to bile acids and of gluconeogenesis via a novel mechanism of transcription regulation linked to the fasted-to-fed cycle. J Biol Chem (2003) 1.44
Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation. J Peripher Nerv Syst (2005) 1.37
Adipose subtype-selective recruitment of TLE3 or Prdm16 by PPARγ specifies lipid storage versus thermogenic gene programs. Cell Metab (2013) 1.22
Inhibition of class I histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue. Diabetes (2012) 1.22
Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in mice. Cancer Res (2011) 1.21
Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective. J Neurobiol (2006) 1.17
Interactions of estrogen and insulin-like growth factor-I in the brain: molecular mechanisms and functional implications. J Steroid Biochem Mol Biol (2002) 1.17
Identification of the tyrosine phosphatase PTP-MEG2 as an antagonist of hepatic insulin signaling. Cell Metab (2006) 1.15
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity. Clin Cancer Res (2006) 1.15
Sterol dependent regulation of human TM7SF2 gene expression: role of the encoded 3beta-hydroxysterol Delta14-reductase in human cholesterol biosynthesis. Biochim Biophys Acta (2006) 1.12
Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice. Mol Pain (2011) 1.12
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats. Eur J Cancer (2005) 1.11
Aromatase expression by reactive astroglia is neuroprotective. Ann N Y Acad Sci (2003) 1.09
Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2. Proc Natl Acad Sci U S A (2013) 1.08
Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer. Cancer (2012) 1.08
Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database Syst Rev (2011) 1.07
Insights into the mechanism of partial agonism: crystal structures of the peroxisome proliferator-activated receptor gamma ligand-binding domain in the complex with two enantiomeric ligands. J Biol Chem (2007) 1.07
Glia-neuron crosstalk in the neuroprotective mechanisms of sex steroid hormones. Brain Res Brain Res Rev (2005) 1.07
Aromatase: a neuroprotective enzyme. Prog Neurobiol (2003) 1.05
The pharmacological exploitation of cholesterol 7alpha-hydroxylase, the key enzyme in bile acid synthesis: from binding resins to chromatin remodelling to reduce plasma cholesterol. Pharmacol Ther (2007) 1.05
Testosterone decreases reactive astroglia and reactive microglia after brain injury in male rats: role of its metabolites, oestradiol and dihydrotestosterone. Eur J Neurosci (2007) 1.04
Estrogen receptor alpha forms estrogen-dependent multimolecular complexes with insulin-like growth factor receptor and phosphatidylinositol 3-kinase in the adult rat brain. Brain Res Mol Brain Res (2003) 1.04
Selective estrogen receptor modulators decrease reactive astrogliosis in the injured brain: effects of aging and prolonged depletion of ovarian hormones. Endocrinology (2009) 1.04
Ro5-4864, a peripheral benzodiazepine receptor ligand, reduces reactive gliosis and protects hippocampal hilar neurons from kainic acid excitotoxicity. J Neurosci Res (2005) 1.03
Ligand for translocator protein reverses pathology in a mouse model of Alzheimer's disease. J Neurosci (2013) 1.02
Treatment with LXR agonists after focal cerebral ischemia prevents brain damage. FEBS Lett (2008) 1.01
N-Acylthiadiazolines, a new class of liver X receptor agonists with selectivity for LXRbeta. J Med Chem (2007) 1.01
Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat. Neurotox Res (2009) 1.01
Antiplasmodial activity of Punica granatum L. fruit rind. J Ethnopharmacol (2009) 1.00
Dissection of the insulin-sensitizing effect of liver X receptor ligands. Mol Endocrinol (2007) 1.00
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats. J Pain Res (2012) 1.00
Insights in the regulation of cholesterol 7alpha-hydroxylase gene reveal a target for modulating bile acid synthesis. Hepatology (2007) 1.00
Selective oestrogen receptor (ER) modulators reduce microglia reactivity in vivo after peripheral inflammation: potential role of microglial ERs. J Endocrinol (2008) 0.98
Cross-talk between estrogen receptors and insulin-like growth factor-I receptor in the brain: cellular and molecular mechanisms. Front Neuroendocrinol (2006) 0.98
Steroids and glial cell function. Glia (2006) 0.98
Evaluation of neuroactive steroid levels by liquid chromatography-tandem mass spectrometry in central and peripheral nervous system: effect of diabetes. Neurochem Int (2007) 0.98
Estrogen receptor beta and the progression of prostate cancer: role of 5alpha-androstane-3beta,17beta-diol. Endocr Relat Cancer (2010) 0.98
Validation of the Italian version of the Neuropathic Pain Symptom Inventory in peripheral nervous system diseases. Neurol Sci (2009) 0.98
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system. Curr Med Chem (2009) 0.98
Role of MAPKs in platinum-induced neuronal apoptosis. Neurotoxicology (2009) 0.97
Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors. J Med Chem (2009) 0.97
Prenatal stress causes alterations in the morphology of microglia and the inflammatory response of the hippocampus of adult female mice. J Neuroinflammation (2012) 0.97
Sex differences in the inflammatory response of primary astrocytes to lipopolysaccharide. Biol Sex Differ (2011) 0.95
In situ electroporation of surface-bound siRNAs in microwell arrays. Lab Chip (2012) 0.95
Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale. J Peripher Nerv Syst (2011) 0.95
Aromatase distribution in the monkey temporal neocortex and hippocampus. Brain Res (2008) 0.95
Sex hormones and brain aging. Exp Gerontol (2004) 0.95
Interactions between neuroactive steroids and reelin haploinsufficiency in Purkinje cell survival. Neurobiol Dis (2009) 0.95
Neuroprotective actions of selective estrogen receptor modulators. Psychoneuroendocrinology (2009) 0.95
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats. Eur J Pain (2009) 0.95
GABA receptor-mediated effects in the peripheral nervous system: A cross-interaction with neuroactive steroids. J Mol Neurosci (2006) 0.95
Disruption of the gene encoding 3beta-hydroxysterol Delta-reductase (Tm7sf2) in mice does not impair cholesterol biosynthesis. FEBS J (2008) 0.94
Neuroactive steroids and peripheral neuropathy. Brain Res Rev (2007) 0.94
An antagonist of estrogen receptors blocks the induction of adult neurogenesis by insulin-like growth factor-I in the dentate gyrus of adult female rat. Eur J Neurosci (2003) 0.94
Selective estrogen receptor modulators protect hippocampal neurons from kainic acid excitotoxicity: differences with the effect of estradiol. J Neurobiol (2004) 0.93
Interaction of estrogen receptors with insulin-like growth factor-I and Wnt signaling in the nervous system. Steroids (2009) 0.93
Selective estrogen receptor modulators as brain therapeutic agents. J Mol Endocrinol (2011) 0.93
Peripheral neurotoxicity of platinum-based chemotherapy. Nat Rev Cancer (2008) 0.93
Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study. Am J Hematol (2014) 0.93